HK1164503A1 - Methods for selecting antidepressant medications - Google Patents
Methods for selecting antidepressant medicationsInfo
- Publication number
- HK1164503A1 HK1164503A1 HK12105128.0A HK12105128A HK1164503A1 HK 1164503 A1 HK1164503 A1 HK 1164503A1 HK 12105128 A HK12105128 A HK 12105128A HK 1164503 A1 HK1164503 A1 HK 1164503A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- selecting
- methods
- antidepressant medications
- antidepressant
- medications
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H50/00—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics
- G16H50/30—ICT specially adapted for medical diagnosis, medical simulation or medical data mining; ICT specially adapted for detecting, monitoring or modelling epidemics or pandemics for calculating health indices; for individual health risk assessment
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B50/00—ICT programming tools or database systems specially adapted for bioinformatics
- G16B50/10—Ontologies; Annotations
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
- G16H20/10—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to drugs or medications, e.g. for ensuring correct administration to patients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
- G16H10/00—ICT specially adapted for the handling or processing of patient-related medical or healthcare data
- G16H10/60—ICT specially adapted for the handling or processing of patient-related medical or healthcare data for patient-specific data, e.g. for electronic patient records
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US44854703P | 2003-02-20 | 2003-02-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1164503A1 true HK1164503A1 (en) | 2012-09-21 |
Family
ID=32908604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK12105128.0A HK1164503A1 (en) | 2003-02-20 | 2012-05-24 | Methods for selecting antidepressant medications |
Country Status (7)
Country | Link |
---|---|
US (6) | US8401801B2 (xx) |
EP (2) | EP2393028B1 (xx) |
JP (3) | JP5348840B2 (xx) |
DK (2) | DK2393028T3 (xx) |
ES (2) | ES2557885T3 (xx) |
HK (1) | HK1164503A1 (xx) |
WO (1) | WO2004074456A2 (xx) |
Families Citing this family (38)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8688385B2 (en) * | 2003-02-20 | 2014-04-01 | Mayo Foundation For Medical Education And Research | Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype |
EP2393028B1 (en) | 2003-02-20 | 2015-09-30 | Mayo Foundation For Medical Education And Research | Methods for selecting antidepressant medications |
ES2825949T3 (es) * | 2004-09-30 | 2021-05-17 | Vanda Pharmaceuticals Inc | Métodos para administrar iloperidona |
AU2006320633A1 (en) * | 2005-11-29 | 2007-06-07 | Children's Hospital Medical Center | Optimization and individualization of medication selection and dosing |
US20100273147A1 (en) * | 2006-01-19 | 2010-10-28 | Valenti Samuel R | Medical diagnostic system and methods |
US8380539B2 (en) * | 2006-05-09 | 2013-02-19 | University Of Louisville Research Foundation, Inc. | Personalized medicine management software |
WO2008052167A2 (en) * | 2006-10-27 | 2008-05-02 | Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services | Methods to identify patients at risk of developing adverse events during treatment with antidepressant medication |
WO2008076434A2 (en) * | 2006-12-18 | 2008-06-26 | Theragenetics | Predicting a response to risperidone |
US8099298B2 (en) | 2007-02-14 | 2012-01-17 | Genelex, Inc | Genetic data analysis and database tools |
US7795033B2 (en) * | 2007-03-19 | 2010-09-14 | The United States Of America As Represented By The Department Of Health And Human Services | Methods to predict the outcome of treatment with antidepressant medication |
AU2008310577A1 (en) * | 2007-10-12 | 2009-04-16 | Patientslikeme, Inc. | Self-improving method of using online communities to predict health-related outcomes |
WO2010048020A1 (en) * | 2008-10-20 | 2010-04-29 | Epitome Pharmaceuticals Limited | Methods and systems for improved pharmaceutical intervention in coagulation control |
US8315815B2 (en) | 2008-12-30 | 2012-11-20 | The Invention Science Fund I, Llc | Computational methods and systems for suggesting modulators of CYP450 as treatment options |
US8321151B2 (en) | 2008-12-30 | 2012-11-27 | The Invention Science Fund I, Llc | Computational methods and systems for treatment in relation to modulation of CYP450 enzyme activity |
US8073632B2 (en) * | 2008-12-30 | 2011-12-06 | The Invention Science Fund I, Llc | Computational methods and systems for treatment in relation to modulation of CYP450 enzyme activity |
WO2010126577A1 (en) | 2009-04-30 | 2010-11-04 | Patientslikeme, Inc. | Systems and methods for encouragement of data submission in online communities |
US9558320B2 (en) * | 2009-10-26 | 2017-01-31 | Genomas, Inc. | Physiogenomic method for predicting drug metabolism reserve for antidepressants and stimulants |
JP5672705B2 (ja) * | 2010-01-26 | 2015-02-18 | 住友化学株式会社 | 発光装置およびその製造方法 |
WO2012054681A2 (en) * | 2010-10-21 | 2012-04-26 | Mayo Foundation For Medical Education And Research | Methods for selecting medications for treating patients having attention-deficit hyperactivity disorder |
CN105956398A (zh) * | 2010-11-01 | 2016-09-21 | 皇家飞利浦电子股份有限公司 | 包括专有测试的特许使用费的自动化代理的体外诊断测试 |
US20120209081A1 (en) * | 2011-02-11 | 2012-08-16 | Abbas Sadeghian | Method of preventing patient injury |
US9779214B2 (en) | 2012-01-06 | 2017-10-03 | Molecular Health Gmbh | Systems and methods for personalized de-risking based on patient genome data |
WO2014055398A1 (en) * | 2012-10-05 | 2014-04-10 | Siemens Healthcare Diagnostics Inc. | Method for detecting an increased risk or incidence of colorectal cancer |
US10210312B2 (en) | 2013-02-03 | 2019-02-19 | Youscript Inc. | Systems and methods for quantification and presentation of medical risk arising from unknown factors |
US20140243211A1 (en) | 2013-02-28 | 2014-08-28 | Indiana University Research & Technology Corporation | Blood biomarkers for suicidality |
US20140274764A1 (en) * | 2013-03-15 | 2014-09-18 | Pathway Genomics Corporation | Method and system to predict response to treatments for mental disorders |
US20170253928A1 (en) * | 2013-03-15 | 2017-09-07 | Pathway Genomics Corporation | Method and system to predict response to treatments for mental disorders |
US20190055603A1 (en) * | 2015-04-28 | 2019-02-21 | Proove Biosciences, Inc. | System and method for processing genotype information relating to drug metabolism |
WO2016176482A1 (en) * | 2015-04-28 | 2016-11-03 | Proove Biosciences, Inc. | System and method for processing genotype information relating to non-opioid response |
US10395759B2 (en) | 2015-05-18 | 2019-08-27 | Regeneron Pharmaceuticals, Inc. | Methods and systems for copy number variant detection |
KR20180018706A (ko) | 2015-06-12 | 2018-02-21 | 인디애나 유니버시티 리서치 앤드 테크놀로지 코퍼레이션 | 조합된 게놈 및 임상 위험 평가를 이용한 자살경향의 예측 |
CA3105451A1 (en) | 2017-05-12 | 2018-11-15 | Indiana University Research And Technology Corporation | Precision medicine for treating and preventing suicidality |
CN111742370A (zh) | 2017-05-12 | 2020-10-02 | 密歇根大学董事会 | 个体和队列药理学表型预测平台 |
JP7320345B2 (ja) * | 2017-10-27 | 2023-08-03 | シスメックス株式会社 | 遺伝子解析方法、遺伝子解析装置、遺伝子解析システム、プログラム、および記録媒体 |
WO2019083024A1 (ja) * | 2017-10-27 | 2019-05-02 | シスメックス株式会社 | 遺伝子解析方法、遺伝子解析装置、管理サーバ、遺伝子解析システム、プログラム、および記録媒体 |
US10950354B1 (en) * | 2018-03-02 | 2021-03-16 | Allscripts Software, Llc | Computing system for pharmacogenomics |
US11894139B1 (en) | 2018-12-03 | 2024-02-06 | Patientslikeme Llc | Disease spectrum classification |
CN110643689A (zh) * | 2019-10-29 | 2020-01-03 | 陕西佰美基因股份有限公司 | 一种检测HTR2A基因rs6313位点的TaqMan探针实时荧光PCR方法及其引物探针组合 |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5252743A (en) | 1989-11-13 | 1993-10-12 | Affymax Technologies N.V. | Spatially-addressable immobilization of anti-ligands on surfaces |
US5833599A (en) | 1993-12-13 | 1998-11-10 | Multum Information Services | Providing patient-specific drug information |
CA2267070A1 (en) | 1996-11-06 | 1998-05-14 | Sequenom, Inc. | Compositions and methods for immobilizing nucleic acids to solid supports |
US20020010595A1 (en) * | 1998-02-27 | 2002-01-24 | Kapp Thomas L. | Web-based medication management system |
IL138620A0 (en) * | 1998-04-03 | 2001-10-31 | Triangle Pharmaceuticals Inc | Systems, methods and computer program products for guiding the selection of therapeutic treatment regimens |
US6183963B1 (en) * | 1998-10-23 | 2001-02-06 | Signalgene | Detection of CYP1A1, CYP3A4, CYP2D6 and NAT2 variants by PCR-allele-specific oligonucleotide (ASO) assay |
JP2003516111A (ja) | 1999-02-22 | 2003-05-13 | バリアジェニックス インコーポレーテッド | 疾病の治療法の決定において有用性を有する遺伝子配列変異 |
US20010034023A1 (en) * | 1999-04-26 | 2001-10-25 | Stanton Vincent P. | Gene sequence variations with utility in determining the treatment of disease, in genes relating to drug processing |
US6297014B1 (en) * | 1999-07-02 | 2001-10-02 | Cedars-Sinai Medical Center | Genetic test to determine non-responsiveness to statin drug treatment |
US20020012921A1 (en) * | 2000-01-21 | 2002-01-31 | Stanton Vincent P. | Identification of genetic components of drug response |
JP2001256305A (ja) * | 2000-03-13 | 2001-09-21 | Kazutoshi Mogi | 遺伝子検査データ活用方法 |
US7206699B2 (en) * | 2000-04-18 | 2007-04-17 | Virco N.V. | Methods for measuring therapy resistance |
US20020010552A1 (en) * | 2000-05-26 | 2002-01-24 | Hugh Rienhoff | System for genetically characterizing an individual for evaluation using genetic and phenotypic variation over a wide area network |
US20020076774A1 (en) * | 2000-06-21 | 2002-06-20 | Chunhua Yan | Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
JP2002024385A (ja) | 2000-06-30 | 2002-01-25 | Coreflow Technologies:Kk | 遺伝子情報管理システム及びその管理方法 |
AU2001278599A1 (en) | 2000-08-10 | 2002-02-18 | Glaxo Group Limited | A global electronic medicine response profile testing network |
US6812339B1 (en) * | 2000-09-08 | 2004-11-02 | Applera Corporation | Polymorphisms in known genes associated with human disease, methods of detection and uses thereof |
WO2002025519A1 (fr) * | 2000-09-20 | 2002-03-28 | Kabushiki Kaisha Toshiba | Procede visant a fournir une information de diagnostic a base de genes, terminal fournissant l'information, et terminal de reception de l'information |
AU2001275020A1 (en) * | 2000-09-21 | 2002-04-02 | Theradoc.Com, Inc. | Systems and methods for manipulating medical data via a decision support system |
US6450956B1 (en) | 2000-11-06 | 2002-09-17 | Siemens Corporate Research, Inc. | System and method for treatment and outcome measurement analysis |
JP2002197189A (ja) | 2000-12-26 | 2002-07-12 | Sanyo Electric Co Ltd | 薬品テーラーメイドシステム |
JP2002245171A (ja) | 2001-02-13 | 2002-08-30 | Canon Sales Co Inc | 医療情報管理装置、その方法、プログラム、記憶媒体 |
AU2002244568A1 (en) * | 2001-03-14 | 2002-09-24 | Mcgill University | Individualization of therapy with antipsychotics |
JP2002318858A (ja) * | 2001-04-19 | 2002-10-31 | Toshitada Kameda | 医療計画作成支援システム及びコンピュータプログラム |
US20020187483A1 (en) * | 2001-04-20 | 2002-12-12 | Cerner Corporation | Computer system for providing information about the risk of an atypical clinical event based upon genetic information |
WO2003008637A2 (en) | 2001-07-17 | 2003-01-30 | Xanthus Life Sciences, Inc. | Use of genotyping in the individualization of therapy |
US7529685B2 (en) * | 2001-08-28 | 2009-05-05 | Md Datacor, Inc. | System, method, and apparatus for storing, retrieving, and integrating clinical, diagnostic, genomic, and therapeutic data |
US7461006B2 (en) * | 2001-08-29 | 2008-12-02 | Victor Gogolak | Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data |
US20030105596A1 (en) | 2001-10-29 | 2003-06-05 | Goldstein David Benjamin | Methods for evaluating responses of a group of test subjects to a drug or other clinical treatment and for predicting responses in other subjects |
WO2003039234A2 (en) * | 2001-11-06 | 2003-05-15 | David Pickar | Pharmacogenomics-based system for clinical applications |
US20030157110A1 (en) * | 2002-01-07 | 2003-08-21 | Millennium Pharmaceuticals, Inc. | Methods for the treatment of metabolic disorders, including obesity and diabetes |
US7274707B2 (en) * | 2002-03-07 | 2007-09-25 | Koninklijke Philips Electronics N. V. | Coexistence of stations capable of different modulation schemes in a wireless local area network |
US20030204415A1 (en) * | 2002-04-30 | 2003-10-30 | Calvin Knowlton | Medical data and medication selection and distribution system |
US7809585B1 (en) | 2002-06-12 | 2010-10-05 | Anvita, Inc. | System and method for patient-specific optimization of medical therapy by simultaneous symbolic reasoning in all clinical dimensions |
EP2393028B1 (en) | 2003-02-20 | 2015-09-30 | Mayo Foundation For Medical Education And Research | Methods for selecting antidepressant medications |
US8688385B2 (en) | 2003-02-20 | 2014-04-01 | Mayo Foundation For Medical Education And Research | Methods for selecting initial doses of psychotropic medications based on a CYP2D6 genotype |
US20040193446A1 (en) | 2003-03-27 | 2004-09-30 | Mayer Steven Lloyd | System and method for managing a patient treatment program including a prescribed drug regimen |
US20050069936A1 (en) | 2003-09-26 | 2005-03-31 | Cornelius Diamond | Diagnostic markers of depression treatment and methods of use thereof |
WO2005038049A2 (en) | 2003-10-06 | 2005-04-28 | Heinrich Guenther | System and method for optimizing drug therapy |
US7813880B2 (en) | 2004-03-25 | 2010-10-12 | University Of Maryland, Baltimore | Apparatus and method for providing optimal concentrations for medication infusions |
EP1751673A4 (en) | 2004-05-03 | 2008-06-25 | Cygene Lab Inc | PROCESS AND SYSTEM FOR COMPREHENSIVE, KNOWLEDGE BASED ANONYMOUS TESTS AND REPORTS AND FOR THE PROVISION OF SELECTIVE ACCESS TO RESULTS AND REPORTS |
US20050260549A1 (en) | 2004-05-19 | 2005-11-24 | Feierstein Roslyn E | Method of analyzing question responses to select among defined possibilities and means of accomplishing same |
US7546285B1 (en) | 2004-09-24 | 2009-06-09 | Sprint Communications Company L.P. | System and method for scoring development concepts |
AU2005319028B2 (en) | 2004-12-21 | 2010-09-16 | Academia Sinica | Genetic variants of VKORCI predicting warfarin sensitivity |
WO2006075254A2 (en) | 2005-01-13 | 2006-07-20 | Progenika Biopharma, S.A. | Methods and products for in vitro genotyping |
EP1906973A2 (en) | 2005-06-14 | 2008-04-09 | Baxter International Inc. | Pharmaceutical formulations for minimizing drug-drug interactions |
FR2887663A1 (fr) * | 2005-06-24 | 2006-12-29 | Ippm Holding Sa | Procede et systeme d'information pour generer des donnees d'optimisation d'un traitement medical, et equipement mis en oeuvre dans ce systeme |
AU2006320633A1 (en) | 2005-11-29 | 2007-06-07 | Children's Hospital Medical Center | Optimization and individualization of medication selection and dosing |
-
2004
- 2004-02-20 EP EP11001368.7A patent/EP2393028B1/en not_active Expired - Lifetime
- 2004-02-20 US US10/545,931 patent/US8401801B2/en active Active
- 2004-02-20 ES ES11001368.7T patent/ES2557885T3/es not_active Expired - Lifetime
- 2004-02-20 EP EP04713404.4A patent/EP1599576B1/en not_active Expired - Lifetime
- 2004-02-20 WO PCT/US2004/005113 patent/WO2004074456A2/en active Application Filing
- 2004-02-20 DK DK11001368.7T patent/DK2393028T3/en active
- 2004-02-20 JP JP2006503753A patent/JP5348840B2/ja not_active Expired - Lifetime
- 2004-02-20 ES ES04713404.4T patent/ES2575903T3/es not_active Expired - Lifetime
- 2004-02-20 DK DK04713404.4T patent/DK1599576T3/en active
-
2010
- 2010-01-13 JP JP2010004875A patent/JP5438524B2/ja not_active Expired - Lifetime
- 2010-07-08 JP JP2010155468A patent/JP5438610B2/ja not_active Expired - Lifetime
-
2012
- 2012-05-24 HK HK12105128.0A patent/HK1164503A1/xx not_active IP Right Cessation
-
2013
- 2013-03-11 US US13/792,365 patent/US20130311202A1/en not_active Abandoned
-
2015
- 2015-01-30 US US14/610,941 patent/US9111028B2/en not_active Expired - Lifetime
- 2015-11-13 US US14/940,375 patent/US20160237494A1/en not_active Abandoned
-
2019
- 2019-05-15 US US16/413,125 patent/US20200048712A1/en not_active Abandoned
-
2023
- 2023-02-01 US US18/104,717 patent/US20230420139A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US9111028B2 (en) | 2015-08-18 |
EP2393028A2 (en) | 2011-12-07 |
JP5348840B2 (ja) | 2013-11-20 |
US20150148336A1 (en) | 2015-05-28 |
WO2004074456A3 (en) | 2006-07-27 |
EP2393028A3 (en) | 2012-02-29 |
US20070003931A1 (en) | 2007-01-04 |
JP5438610B2 (ja) | 2014-03-12 |
EP1599576A4 (en) | 2008-02-13 |
DK1599576T3 (en) | 2016-08-01 |
EP2393028B1 (en) | 2015-09-30 |
EP1599576B1 (en) | 2016-04-27 |
ES2557885T3 (es) | 2016-01-29 |
US20230420139A1 (en) | 2023-12-28 |
ES2575903T3 (es) | 2016-07-04 |
US20130311202A1 (en) | 2013-11-21 |
US8401801B2 (en) | 2013-03-19 |
DK2393028T3 (en) | 2016-01-11 |
US20200048712A1 (en) | 2020-02-13 |
JP5438524B2 (ja) | 2014-03-12 |
US20160237494A1 (en) | 2016-08-18 |
WO2004074456A2 (en) | 2004-09-02 |
JP2007525154A (ja) | 2007-09-06 |
EP1599576A2 (en) | 2005-11-30 |
JP2010273681A (ja) | 2010-12-09 |
JP2010176661A (ja) | 2010-08-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1164503A1 (en) | Methods for selecting antidepressant medications | |
GB0326439D0 (en) | Methods | |
EP1675596A4 (en) | METHOD | |
GB2405854B (en) | Booklet | |
GB0301117D0 (en) | Method | |
GB0328243D0 (en) | Methods | |
GB0328021D0 (en) | Method | |
GB2401043B (en) | Drug | |
GB0327909D0 (en) | Methods | |
GB0320627D0 (en) | Methods | |
GB0327368D0 (en) | Methods | |
GB0315827D0 (en) | Methods | |
GB0304632D0 (en) | Method | |
EP1694837A4 (en) | METHOD | |
EP1612264A4 (en) | ORGAN MOLDING | |
GB0328747D0 (en) | Methods | |
GB0307076D0 (en) | Methods | |
GB0305252D0 (en) | Methods | |
GB0323793D0 (en) | Methods | |
EP1624073A4 (en) | DRUG | |
GB0320548D0 (en) | Supports | |
GB0303536D0 (en) | Method | |
HU0300249V0 (en) | Ring for penial | |
GB0306636D0 (en) | Say-it note | |
HU0302804D0 (en) | Round-sewing-machine for haemorrhoidectomy |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20200216 |